This paper attempts to evaluate the possible gains and losses arising from the gradual opening up of pharmaceutical trade between India and Pakistan. The comparative advantages of both countries at a disaggregated level is explained followed by a qualitative analysis of various perceptions and experiences of Pakistan’s pharmaceutical manufacturers with respect to trade with India.
- sneha pawar
- 18 Feb 2023
- 10 Nov 2022
- 16 Nov 2021